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Abstract
Aim: The Japan Society of Obstetrics and Gynecology implemented a registry report 
system for the clinical practice of assisted reproductive technology in 1986. The ag-
gregated results from 1992 to 2014 are reported herein.
Methods and Results: The total number of registered treatments was 393 745 cycles, 
of which 66 550 were pregnancy cycles and 46 008 were cycles with a live birth. 
Compared to the number of registered treatments in 2008, when the cycle- based 
registry was newly introduced, there was a 2.07- fold increase in the total number of 
treatments and a 2.25- fold increase in the number of cycles with a live birth. As the 
average age of patients who receive assisted reproductive technology has become 
markedly higher year by year, the most common age of those patients who received 
assisted reproductive technology in 2014 was 40 years.
Conclusion: The total numbers of both assisted reproductive technology treatments 
and assisted reproductive technology live births are likely to be higher in the future. In 
addition, the trend toward aging patients seems to be continuing into the future.
K E Y W O R D S
assisted reproductive technology, in vitro fertilization, intracytoplasmic sperm injection, Japan 
Society of Obstetrics and Gynecology
1  | INTRODUCTION
The Japan Society of Obstetrics and Gynecology (JSOG) implemented a 
registry report system for the clinical practice of assisted reproductive 
technology (ART) in 1986. Starting with the report for fiscal year 1989 
(The First Report),1 the JSOG continuously has reported the clinical out-
comes of ART.2–25 Since 2008, the JSOG has implemented an online 
cycle- based registry system (individual surveys). The most recent version 
of the annual report is 2014 (the period from January 1 to December 31, 
2014) that was published previously in Japanese.25 As Japan has been 
the largest contributor of ART in terms of the annual amount of practice, 
herewith is presented the aggregate results for Japan.
2  | MATERIALS AND METHODS
For all patients who began treatment between January 1 and 
December 31, 2014, data for all treatment cycles that were 
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TABLE  1 Cycle- based registry form: clinical outcome of assisted reproductive technology
Patient ID number (req) Unique ID for patient
Use of governmental support system for 
ART (req)
1. Yes
2. No
3. Unknown
Woman’s age at starting of therapy (req) (      ) years old
Man’s age at starting of therapy (req) (      ) years old
Height and body weight at starting of 
therapy 
Height (      ) cm
Body weight (      ) kg
Pregnancy history Gravida (      )
Para (      )
Cause of infertility (req) 1. Tubal dysfunction
2. Endometriosis
3. Antisperm antibody
4. Male factor
5. Unknown
6. Others (      )
7. Oocyte cryopreservation (medical indication)
Type of controlled ovarian stimulation 1. Natural
2. CC
3. CC + hMG or FSH
4. hMG or FSH
5. GnRH agonist + hMG or FSH
6. GnRH antagonist + hMG or FSH
7. Others (      )
8. Hormone replacement cycle
Method of oocyte pick up (req) 1. Failed
2. Endovaginal ultrasonography
3. Laparoscopy
4. Use of thawed egg or embryo
5. Others (      )
Type of used egg or embryo (req) 1. Fresh egg or embryo 
2. Frozen thawed embryo 
3. Frozen thawed egg 
※ If check (2. Frozen thawed embryo), input the registration number at oocyte pick up (      )
Therapeutic method (req) 1. IVF–ET
2. GIFT
3. ICSI
4. IVF-ET + ICSI
5. Thawed embryo
6. Others (      )
7. Oocyte cryopreservation (medical indication)
Type of sperm collection 1. Ejaculated sperm
2. TESE
3. Others (      )
Sperm analysis ※ If check (1. Ejaculated sperm) in (Type of sperm collection), input the results of sperm analysis 
Concentration (      ) ×106/mL (the second decimal place) 
Motility (      ) %
If check (1. Fresh eggs or embryo) in (Types of used egg or embryo), input of following two items is necessary
Number of eggs retrieved (      )
Number of fertilized eggs (      )
If check (2. Frozen thawed embryo) in (Types of used egg or embryo), input of following item is necessary
Number of thawed embryos (      )
If check (3. Frozen thawed egg) in (Types of used egg or embryo), input of following two items is necessary
Number of thawed eggs (      )
Number of fertilized eggs after thawed (      )
(Continues)
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Patient ID number (req) Unique ID for patient
If check any of three alternatives in (Types of used egg or embryo), input of following seven items is necessary
Stage of embryo at embryo transfer 1. Egg (unfertilized)
2. Cleavage embryos
3. Blastocysts
4. ET cancellation
5. Others (      )
Number of egg or embryo transfers (      )
Number of frozen egg or embryos (      )
Assisted hatching 1. Yes
2. No
Luteal support 1. None
2. Progesterone (P)
3. hCG
4. hCG + P
5. Estrogen + P
6. Others (      )
Complications 1. None
2. Bleeding
3. Infection
4. OHSS (more than Stage II)
5. Others (      )
Having pregnancy or not 1. None
2. Clinical pregnancy (Evidence by ultrasound of an intrauterine sac with or without a fetal heart) 
(Date of embryo transfer [day/month/year]) 
※ If check (2. Clinical pregnancy), input the (Data items from pregnancy to delivery) form.
3. Undetermined 
※ Reselect (1. None) or (2. Clinical pregnancy) after determined.
req, required; ART, assisted reproductive technology; CC, clomiphene citrate; hMG, human menopausal gonadotropin; FSH, follicle- stimulating hormone; 
GnRH, gonadotropin- releasing hormone; IVF–ET, in vitro fertilization–embryo transfer; GIFT, gamete intrafallopian transfer; ICSI, intracytoplasmic sperm 
injection; TESE, testicular sperm extraction; OHSS, ovarian hyperstimulation syndrome.
TABLE  1  (Continued)
TABLE  2 Cycle- based registry form: obstetric outcome of pregnancy
Number of gestational sacs (req) (      )
Number of fetal heartbeat (      )
Outcome of pregnancy (req) 1. Miscarriage
2. Ectopic pregnancy
3. Heterotopic pregnancy
4. Elective termination of pregnancy (reason: )
5. Live birth
6. Stillbirth
7. Selective reduction performed (number of fetus before reduction [ ], number of fetuses 
after reduction [ ])
8. Unknown
Number of live births ※ If check (5. Live birth) or (6. Stillbirth) in (Outcome of pregnancy), input is necessary
Number (      ) (Date of delivery [day/month/year])
Style of delivery 1. Vaginal delivery
2. Cesarean delivery
3. Vaginal and cesarean delivery
4. Unknown
Obstetric complications of pregnancy 1. None
2. Yes
3. Unknown
(Continues)
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Finding of the baby
 Sex Gestational 
age
Birthweight State of baby Prognosis after delivery
Live birth or 
stillbirth
Monozygotic Malformation Under 7 days Under 28 days Date of death
1 1. Male 1. (      ) weeks 1. (      ) g 1. Live birth 1. Yes (      ) 1. Survival 1. Survival (Day/month/
year)2. Female 2. Unknown 2. Unknown 2. Stillbirth 2. No 2. Death 2. Death
3. Unknown    3. Unknown 3. Unknown 3. Unknown
2 1. Male 1. (      ) weeks 1. (      ) g 1. Live birth 1. Yes (      ) 1. Survival 1. Survival (Day/month/
year)2. Female 2. Unknown 2. Unknown 2. Stillbirth 2. No 2. Death 2. Death
3. Unknown    3.Unknown 3. Unknown 3. Unknown
3 1. Male 1. (      ) weeks 1. (      ) g 1. Live birth 1. Yes (      ) 1. Survival 1. Survival (Day/month/
year)2. Female 2. Unknown 2. Unknown 2. Stillbirth 2. No 2. Death 2. Death
3. Unknown    3. Unknown 3. Unknown 3. Unknown
4 1. Male 1. (      ) weeks 1. (      ) g 1. Live birth 1. Yes (      ) 1. Survival 1. Survival (Day/month/
year)2. Female 2. Unknown 2. Unknown 2. Stillbirth 2. No 2. Death 2. Death
3. Unknown    3. Unknown 3. Unknown 3. Unknown
req, required.
F IGURE  1 Age distribution of the 
women who were treated with assisted 
reproductive technology procedures 
in Japan in 2014. Adapted from Japan 
Society of Obstetrics and Gynecology 
ART Databook 2014 (https://plaza.umin.
ac.jp/~jsog-art/2014data_201609.pdf)
F IGURE  2 Age distribution of the 
women who were treated with assisted 
reproductive technology procedures 
in Japan in 2008. Adapted from Japan 
Society of Obstetrics and Gynecology 
ART Databook 2008 (https://plaza.umin.
ac.jp/~jsog-art/2008data_pdf.pdf)
TABLE  2  (Continued)
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F IGURE  3 Number of cycles in 
each assisted reproductive technology 
procedure in Japan between 1992 and 
2014. Adapted from Japan Society 
of Obstetrics and Gynecology ART 
Databook 2014 (https://plaza.umin.
ac.jp/~jsog-art/2014data_201609.pdf). 
FET, frozen–thawed embryo transfer; ICSI, 
intracytoplasmic sperm injection; IVF, in 
vitro fertilization
F IGURE  4 Number of live births 
after assisted reproductive technology 
procedures in Japan between 1992 
and 2014. Adapted from Japan Society 
of Obstetrics and Gynecology ART 
Databook 2014 (https://plaza.umin.
ac.jp/~jsog-art/2014data_201609.pdf). 
FET, frozen–thawed embryo transfer; ICSI, 
intracytoplasmic sperm injection; IVF, in 
vitro fertilization
F IGURE  5 Rates of pregnancy, live 
birth, and miscarriage at each age in Japan 
in 2014. Adapted from Japan Society of 
Obstetrics and Gynecology ART Databook 
2014 (https://plaza.umin.ac.jp/~jsog-
art/2014data_201609.pdf). ET, embryo 
transfer
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performed at all ART treatment facilities nationwide were entered for 
each treatment cycle by using the online registry system by the end 
of November, 2015. The contents that were investigated are shown 
in Tables 1 and 2.
3  | RESULTS AND DISCUSSION
There were 598 registered ART facilities in 2014 and the ART 
treatments at all of these facilities were registered. The number 
of facilities that actually provided ART treatment in 2014 was 
574; the number of implemented cycles was zero at 24 facilities. 
Figure 1 shows the age distribution of the patients for all regis-
tered treatment cycles. The total number of registered treatments 
was 393 745 cycles, of which 66 550 were pregnancy cycles and 
46 008 were cycles with a live birth. Compared to the number of 
registered treatments in 2008 (Figure 2), there was a 2.07- fold in-
crease in the total number of treatments and a 2.25- fold increase 
in the number of cycles with a live birth. The age of the patients 
who receive ART has become markedly higher each year and the 
most common age of those patients who received ART in 2014 was 
40 years. The trend toward an increasing patient age is thought to 
continue into the future. Figures 3 and 4 show the annual changes 
in the number of registered cycles and live births since registration 
began in 1992. The increases in the total number of ART treat-
ments and ART live births are thought to continue for some time 
into the future. The total number of ART live births that was reg-
istered between 1992, the year in which registration began, and 
2014 was 431 626.
Figure 5 shows the outcomes of ART by patient age for all treat-
ment cycles. As the age increases, the success rate decreases and the 
rate of miscarriage increases. Compared to the 2008 results (Figure 6), 
these outcomes represent a slight increase, but no major change.
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